TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB

Anti-Infective Agents; Chromones; Enzyme Inhibitors; Isoenzymes; Membrane Proteins; Morpholines; NF-kappa B; Nitric Oxide Donors; Tumor Necrosis Factor-alph

Abstract :

[en] TNF-alpha plays a key role in rheumatoid arthritis, but its effect on chondrocyte survival is still conflicting. In the present study, we tested how TNF-alpha influences chondrocyte survival in response to nitric oxide (NO)-related apoptotic signals, which are abundant during rheumatoid arthritis. Human primary articular chondrocytes or cartilage explants were pretreated with TNF-alpha for 24 hours and then treated with the proapoptotic NO donor sodium-nitro-prusside (SNP) for an additional 24 hours. TNF-alpha pretreatment markedly protected chondrocytes from SNP-induced cell death. Preincubation of chondrocytes with TNF-alpha inhibited both SNP-induced high-molecular weight DNA fragmentation and annexin V-FITC binding. Of interest, TNF-alpha induced persistent nuclear factor-kappaB (NF-kappaB)-DNA binding activity even in the presence of SNP, mirroring apoptosis protection effects. Both the TNF-alpha antiapoptotic effect and NF-kappaB-DNA binding activity were significantly inhibited by NF-kappaB inhibitors, Bay 11-7085, MG-132, and adenovirus-expressing mutated IkappaB-alpha. Phosphatidylinositol-3 kinase inhibitor LY 294002 also markedly inhibited the antiapoptotic effect of TNF-alpha. In primary chondrocytes, TNF-alpha induced expression of the antiapoptotic protein Cox-2, which persisted in the presence of SNP, and a specific Cox-2 inhibitor significantly blocked the TNF-alpha protective effect. We therefore conclude that TNF-alpha-mediated protection of chondrocytes from NO-induced apoptosis acts through NF-kappaB and requires Cox-2 activity.

Disciplines :

Rheumatology

Author, co-author :

Relic, Biserka ; Université de Liège - ULiège > Rhumatologie

Bentires-Alj, Mohamed

Ribbens, Clio ; Université de Liège - ULiège > Rhumatologie

Franchimont, Nathalie

Guerne, Pierre-Andre

Benoit, Valerie

Merville, Marie-Paule ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale

Bours, Vincent ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique générale et humaine

Malaise, Michel ; Université de Liège - ULiège > Département des sciences cliniques > Rhumatologie

Language :

English

Title :

TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB

Publication date :

2002

Journal title :

Laboratory Investigation

ISSN :

0023-6837

eISSN :

1530-0307

Publisher :

Lippincott Williams & Wilkins, Hagerstown, United States - Maryland

Volume :

Issue :

Pages :

1661-1672

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 29 June 2011

Statistics

Number of views

86 (3 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Aizawa T, Kon T, Einhorn TA, and Gerstenfeld LC (2001). Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha. J Orthop Res 19:785-796.
Amin AR, Attur M, and Abramson SB (1999). Nitric oxide synthase and cyclooxygenases: Distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol 11:202-209.
Aupperle K, Bennett B, Han Z, Boyle D, Manning A, and Firestein G (2001). NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes. J Immunol 166:2705-2711.
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, and Dorken B (1997). Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100:2961-2969.
Barkett M and Gilmore TD (1999). Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18:6910-6924.
Beg AA, Sha WC, Bronson RT, and Baltimore D (1995). Constitutive NF-kappa B activation, enhanced granulopoiesis. and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev 9:2736-2746.
Bertrand F, Atti A, Cadoret A, L'Allemain G, Robin H, Lascols O, Capeau J, and Cherqui G (1998). A role for nuclear factor kappaB in the antiapoptotic function of insulin. J Biol Chem 273:2931-2938.
Blanco FJ, Ochs RL, Schwarz H, and Lotz M (1995). Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146:75-85.
Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, and Galdo F (1998). Osteoarthritis chondrocytes die by apoptosis: A possible pathway for osteoarthritis pathology. Arthritis Rheum 41:284-289.
Bondenson J, Brennan F, Foxwell B, and Feldmann M (2000). Effective adenoviral transfer of IkBα into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines Is nuclear factor-κB dependent. J Rheumatol 27:2078-2089.
Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, and Merville MP (2000). Nuclear factor-kappa B. cancer, and apoptosis. Biochem Pharmacol 60: 1085-1089.
Bowle A and O'Neill LA (2000). Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13-23.
Brown K, Park S, Kanno T, Franzoso G, and Siebenlist U (1993). Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci USA 90:2532-2536.
Bureau F, Delhalle S, Bonizzi G, Fievez L, Dogne S, Kirschvink N, Vanderplasschen A, Merville MP, Bours V, and Lekeux P (2000). Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J Immunol 165:5822-5830.
Bureau F, Vanderplasschen A, Jaspar F, Minner F, Pastoret PP, Merville MP, Vincent Bours, and Lekeux P (2002). Constitutive nuclear factor-κB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. Blood 99:3683-3691.
Buttke TM, McCubrey JA, and Owen TC (1993). Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J Immunol Methods 157:233-240.
Cao Y and Prescott SM (2002). Many actions of cyclooxygenase-2 in cellular dynamics and In cancer. J Cell Physiol 190:279-286.
Colnot C, Sidhu SS, Balmain N, and Poirier F (2001). Uncoupling of chondrocyte death and vascular invasion in mouse galectin 3 null mutant bones. Dev Biol 229:203-214.
Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, and Bours V (1995). Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11:1835-1841.
DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh S, and Karin M (1996). Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 16:1295-1304.
Feinberg AP and Vogelstein B (1984). "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity." Addendum. Anal Biochem 137:266-267.
Feldmann M and Maini RN (2001). Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 19:163-196.
Fischer BA, Mundle S, and Cole AA (2000). Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis. Microsc Res Tech 50:236-242.
Foglieni C, Meoni C, and Davalli AM (2001). Fluorescent dyes for cell viability: An application on prefixed conditions. Histochem Cell Biol 115:223-229.
Grell M, Zimmermann G, Hulser D, Pfizenmaier K, and Scheurich P (1994). TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol 153:1963-1972.
Habib A, Creminon C, Frobert Y, Grassi J, Pradelles P, and Maclouf J (1993). Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem 268:23448-23454.
Han Z, Boyle DL, Manning AM, and Firestein GS (1998). AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28:197-208.
Handel ML, McMorrow LB, and Gravallese EM (1995). Nuclear factor-kappa B in rheumatoid synovium: Localization of p50 and p65. Arthritis Rheum 38:1762-1770.
Hashimoto S, Ochs RL, Komiya S, and Lotz M (1998). Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 41:1632-1638.
Honda O, Kuroda M, Joia I, Asaumi J, Takeda Y, Akaki S, Togami I, Kanazawa S, Kawasaki S, and Hiraki Y (2000). Assessment of secondary necrosis of Jurkat cells using a new microscopic system and double staining method with annexin V and propidium iodide. Int J Oncol 16:283-288.
Hu X, Janssen WE, Moscinski LC, Bryington M, Dangsupa A, Rezai-Zadeh N, Babbin BA, and Zuckerman KS (2001). An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism. Cancer Res 61:6290-6296.
Jobin C, Panja A, Hellerbrand C, limuro Y, Didonato J, Brenner DA, and Sartor RB (1998). Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J Immunol 160:410-418.
Karin M (1999). How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 18:6867-6874.
Kim HA and Song YW (1999). Apoptotic chondrocyte death in rheumatoid arthritis. Arthritis Rheum 42:1528-1537.
Kuhn K, Hashimoto S, and Lotz M (2000). IL-1 beta protects human chondrocytes from CD95-induced apoptosis. J Immunol 164:2233-2239.
Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, and Ma A (2000). Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350-2354.
Loeser RF, Shanker G, Carlson CS, Gardin JF, Shelton BJ, and Sonntag WE (2000). Reduction in the chondrocyte response to insulin-like growth factor I in aging and osteoarthritis: Studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43:2110-2120.
Lotz M, Hashimoto S, and Kuhn K (1999). Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 7:389-391.
Makarov SS (2001). NF-κB in rheumatoid arthritis: A pivotal regulator of Inflammation, hyperplasia, and tissue destruction. Arthritis Res 3:200-206.
Malicev E, Woyniak G, Knezevic M, Radosavijevic D, and Jeras M (2000). Vitamin C induced apoptosis in human articular chondrocytes. Pflugers Arch 440:R46-R48.
McAdam BF, Mardini IA, Habib A, Burke A, Lawson JA, Kapoor S, and FitzGerald GA (2000). Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest 105:1473-1482.
Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, and Makarov SS (1998). NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 95:13859-13864.
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, and Donner DB (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
Pahl HL (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853-6866.
Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, and Gerritsen ME (1997). Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096-21103.
Reddy SA, Huang JH, and Liao WS (2000). Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J Immunol 164:1355-1363.
Relic B, Guicheux J, Mezin F, Lubberts E, Togninalli D, Garcia I, van den Berg WB, and Guerne PA (2001). IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol 166:2775-2782.
Romashkova JA and Makarov SS (1999). NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90.
Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Takigawa M, Iwata H, and Seo H (2001). Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NFkappaB: Abrogation of tumor necrosis factor alpha effect by proteasome inhibitors. J Bone Miner Res 16:1272-1280.
Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, and Miyasaka N (1995). Nitric oxide production and Inducible nitric oxide synthase expression in Inflammatory arthritides. J Clin Invest 96:2357-2363.
Shimada T, Hiraishi H, and Terano A (2000). Hepatocyte growth factor protects gastric epithelial cells against ceramide-induced apoptosis through induction of cyclooxygenase-2. Life Sci 68:539-546.
Sizemore N, Leung S, and Stark GR (1999). Activation of phosphatidyllnositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19: 4798-4805.
Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK, and Kasahara T (2000). Anti-apoptotic role of focal adhesion kinase (FAK): Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J Biol Chem 275:16309-16315.
Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, and Sonenshein GE (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100:2952-2960.
Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, and Kroemer G (2000). Two distinct pathways leading to nuclear apoptosis. J Exp Med 192:571-580.
Tardif G, Reboul P, Pelletier JP, Geng C, Cloutier JM, and Martel-Pelletier J (1996). Normal expression of type 1 insulin-like growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins. Arthritis Rheum 39:968-978.
Wang D, Westerheide SD, Hanson JL, and Baldwin AS Jr (2000). Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 275:32592-32597.
Weber CK, Liptay S, Wirth T, Adler G, and Schmid RM (2000). Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology 119:1209-1218.
Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, and Sonenshein GE (1996). Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 15:4682-4690.
Yang C, Li SW, Helminen HJ, Khillan JS, Bao Y, and Prockop DJ (1997). Apoptosis of chondrocytes in transgenic mice lacking collagen II. Exp Cell Res 235:370-373.